{
    "code": "02022175",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022175",
    "time": "2020-02-25 12:51:35",
    "許可證字號": "衛署藥輸字第022175號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/06\/03",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "102\/05\/14",
    "發證日期": "87\/05\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202217501",
    "中文品名": "阿雷素凍晶注射劑１０公絲\/小瓶",
    "英文品名": "DOXORUBICIN HCL FOR INJECTION,LYOPHILIZED POWDER 10MG\/VIAL",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神精母細胞癌、乳癌、肺癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "盒裝 小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1011101100  海喬國際股份有限公司",
        "申請商地址": "台北市大同區重慶北路三段276號9樓",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}